Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis

The high mortality associated with VITT was highest among patients with a low platelet count and intracranial hemorrhage. Treatment remains uncertain, but identification of prognostic markers may help guide effective management.

Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Size: 567 KB